Calgary Cancer Centre


What's the latest?

The project overall continues to progress on time and on budget. The detailed design phase, which included every element of the building from floors, walls, elevators, cabinetry, signage and more, is now complete. Over 600 staff, physicians and patient & family advisors helped review thousands of documents over two and a half years.

In response to the COVID-19 situation, the construction of the Calgary Cancer Centre, led by Alberta Infrastructure, continues as scheduled and is considered an essential healthcare construction project. The design builder, PCL, continues to follow the advice of the Chief Medical Officer of Health in ensuring all necessary steps are taken to provide safe workplaces for all Albertans. For more information on essential services, please visit

What is it?

The Calgary Cancer Centre (CCC) will be an internationally recognized, state-of-the-art facility that will provide cancer treatment services and serve as a hub for cutting edge cancer research. It will also increase cancer care capacity in southern Alberta by consolidating and expanding existing services in the Calgary Zone to support integrated and comprehensive cancer care.

The CCC is being built at the Foothills Medical Centre to allow cancer care to be integrated with current key programs and services.

When will it happen?

  • Ground-breaking: Late 2017
  • Project construction: Late 2017 - 2023
  • Detailed Design:  Mid 2017 – Early 2020
  • Operational Readiness: Early 2020 - 2023
  • Building commissioning AHS: 2022-2023
  • Public opening (anticipated): 2023

​Developed in Partnership with: Alberta Infrastructure and Alberta Health

Learn More

We Want to Hear From You

Help us build hope in the new Calgary Cancer Centre. We are partnering with patients, families as well as the community and want to hear from you as we plan for the new building.

Watch the Progress

Image updates every 30 minutes

Stay Connected

Get the latest updates directly with our newsletter.

Sign Up

Follow Us on Twitter